Welcome to our book review site go-pdf.online!
You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Management of MDR-TB
Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) are increasingly encountered in resource-limited settings. In the context of a national response to MDR- and XDR-TB, health workers in TB clinics (in district hospitals and some accredited health centers) will need to diagnose MDR-TB, initiate second-line anti-TB drugs, and monitor MDR-TB treatment. This Field Guide was created to help health workers carry out these tasks. It is a job aid that medical officers and TB nurses are meant to use frequently during the day for quick reference. It is based on the Emergency Update 2008 of Guidelines for Programmatic Management of Drug-resistant Tuberculosis, and may be considered a companion document to these guidelines. It also draws on the experience of the international health NGO Partners In Health (PIH) in many countries. This module should be introduced to health workers in the context of a training course with a strong emphasis on TB-HIV co-management.
A STUDY ON THE HEALTH STATUS OF MULTI DRUG RESISTANT (MDR) TUBERCULOSIS PATIENTS
Tuberculosis (TB) is caused by bacteria called Mycobacterium tuberculosis which mainly affects the lungs of the person. In many circumstances tuberculosis is curable and preventable. Tuberculosis bacteria spread through air from one person to another. When a person with lung TB cough, sneeze or spits, he propels the TB germs into the air and a person just needs to inhale some of these germs to get infected.(World health organisation fact sheet, Oct 2015)According to the World Health Organisation (WHO) one-third of the world's population has latent TB, which means people have been infected by TB bacteria but are not (yet) ill with disease and cannot transmit the disease.
Multidrug Resistant Tuberculosis (MDR-TB): New Insights for the Healthcare Professional: 2013 Edition
Multidrug Resistant Tuberculosis (MDR-TB): New Insights for the Healthcare Professional: 2013 Edition is a ScholarlyPaper™ that delivers timely, authoritative, and intensively focused information about Additional Research in a compact format. The editors have built Multidrug Resistant Tuberculosis (MDR-TB): New Insights for the Healthcare Professional: 2013 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Additional Research in this book to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Multidrug Resistant Tuberculosis (MDR-TB): New Insights for the Healthcare Professional: 2013 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/.
Unpredictable life of MDR
The early life story of a detective who would later become a world-famous detective. The book is a collection of short stories that tell about the early life of MDR (Mihir Dave Roy), and how he went from being a common man to a shining star in the world of espionage.
Multidrug Resistant Tuberculosis (MDR-TB): New Insights for the Healthcare Professional: 2011 Edition
Multidrug Resistant Tuberculosis (MDR-TB): New Insights for the Healthcare Professional: 2011 Edition is a ScholarlyPaper™ that delivers timely, authoritative, and intensively focused information about Multidrug Resistant Tuberculosis (MDR-TB) in a compact format. The editors have built Multidrug Resistant Tuberculosis (MDR-TB): New Insights for the Healthcare Professional: 2011 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Multidrug Resistant Tuberculosis (MDR-TB) in this eBook to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Multidrug Resistant...
Medical Device Regulations: Transitioning from MDD 93/42/EEC to MDR 2017/745
In recent times the need for improving regulatory controls and finding ways to improve the quality and access to safe medical devices has increased. The Medical Devices Directive 93/42/EEC was enforced to provide a harmonised regulatory environment for all medical devices sold within the European Union however new and emerging technologies as well as various well-known incidents within the medical device industry have challenged the current framework and highlighted gaps and a scarcity of skills and expertise. For this reason, there has been an increasing need to update the MDD which led to the development and release of the Medical Device Regulation (EU MDR 2017/745). This has since marked ...
Antibacterial Drug Discovery to Combat MDR
This book compiles the latest information in the field of antibacterial discovery, especially with regard to the looming threat of multi-drug resistance. The respective chapters highlight the discovery of new antibacterial and anti-infective compounds derived from microbes, plants, and other natural sources. The potential applications of nanotechnology to the fields of antibacterial discovery and drug delivery are also discussed, and one section of the book is dedicated to the use of computational tools and metagenomics in antibiotic drug discovery. Techniques for efficient drug delivery are also covered. The book provides a comprehensive overview of the progress made in both antibacterial discovery and delivery, making it a valuable resource for academic researchers, as well as those working in the pharmaceutical industry.
